Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 1294 entries
View as:

A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A (FRONTIER 4)

Phase: N/A Priority: Normal
NCT ID: NCT05685238 Org: User:
Start: 02/13/23 End: 06/30/28 Due: 06/30/29

Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin

Phase: N/A Priority: Normal
NCT ID: NCT01519674 Org: User:
Start: 06/30/12 End: 10/31/13 Due: 10/31/14

A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04569994 Org: User:
Start: 09/30/20 End: 06/23/21 Due: 06/23/22

Investigating Efficacy and Safety of Once-weekly NNC0195-0092 (Somapacitan) Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT02616562 Org: User:
Start: 03/23/16 End: 09/26/24 Due: 09/26/25

A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®

Phase: N/A Priority: Normal
NCT ID: NCT04574076 Org: User:
Start: 10/23/20 End: 06/03/27 Due: 06/03/28

Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06507475 Org: User:
Start: 09/30/24 End: 01/15/25 Due: 01/15/26

Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00729898 Org: User:
Start: 03/31/08 End: 09/30/10 Due: 09/30/11

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01706159 Org: User:
Start: 10/31/12 End: 07/31/13 Due: 07/31/14

Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00737776 Org: User:
Start: 05/31/08 End: 01/31/10 Due: 01/31/11

A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term

Phase: N/A Priority: Normal
NCT ID: NCT07011667 Org: User:
Start: 06/03/25 End: 11/01/28 Due: 11/01/29

Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01620489 Org: User:
Start: 06/14/12 End: 08/20/13 Due: 08/20/14

Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00605111 Org: User:
Start: 12/31/03 End: 10/31/04 Due: 10/31/05

Comparison of Insulin Detemir Produced by the Current Process and the NN729 Process in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01490099 Org: User:
Start: 08/31/06 End: 11/30/06 Due: 11/30/07

Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia

Phase: N/A Priority: Normal
NCT ID: NCT00842894 Org: User:
Start: 05/31/09 End: 10/31/10 Due: 10/31/11

A Research Study in Italy to Understand How the Dose Check App Used With Xultophy® Works in the Treatment of People Living With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06113341 Org: User:
Start: 11/07/24 End: 03/02/26 Due: 03/02/27

Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00097084 Org: User:
Start: 09/30/04 End: 12/31/05 Due: 12/31/06

Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01123980 Org: User:
Start: 05/31/10 End: 06/30/11 Due: 06/30/12

Special Use-results Surveillance on Long Term Use of Sogroya® in Children With Short Stature Due to Growth Hormone Deficiency Where Epiphysial Discs Are Not Closed

Phase: N/A Priority: Normal
NCT ID: NCT06109935 Org: User:
Start: 10/04/23 End: 07/31/26 Due: 07/31/27

Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea

Phase: N/A Priority: Normal
NCT ID: NCT00455858 Org: User:
Start: 11/30/07 End: 10/31/08 Due: 10/31/09

Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00184639 Org: User:
Start: 08/16/04 End: 11/22/05 Due: 11/22/06

SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT04775082 Org: User:
Start: 03/04/21 End: 01/15/27 Due: 01/15/28

A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT03196297 Org: User:
Start: 08/16/17 End: 06/03/20 Due: 06/03/21

Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00698126 Org: User:
Start: 10/31/07 End: 05/31/09 Due: 05/31/10

Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age

Phase: N/A Priority: Normal
NCT ID: NCT00557336 Org: User:
Start: 07/28/03 End: 06/29/05 Due: 06/29/06

A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump

Phase: N/A Priority: Normal
NCT ID: NCT00115973 Org: User:
Start: 06/30/05 End: 01/31/06 Due: 01/31/07